Cannabinoids and triple-negative breast cancer treatment

L Dobovišek, S Borštnar, N Debeljak… - Frontiers in …, 2024 - frontiersin.org
Triple-negative breast cancer (TNBC) accounts for about 10-20% of all breast cancer cases
and is associated with an unfavorable prognosis. Until recently, treatment options for TNBC …

An appraisal of emerging therapeutic targets for multiple sclerosis derived from current preclinical models

A Dixit, HS Savage, JM Greer - Expert Opinion on Therapeutic …, 2023 - Taylor & Francis
Introduction Multiple sclerosis (MS) is a chronic inflammatory, demyelinating, and
neurodegenerative condition affecting the central nervous system (CNS). Although …

Exploring the 1, 3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic

N Gambacorta, V Gasperi, T Guzzo, FS Di Leva… - European Journal of …, 2023 - Elsevier
The discovery of selective agonists of cannabinoid receptor 2 (CB 2) is strongly pursued to
successfully tuning endocannabinoid signaling for therapeutic purposes. However, the …

Expression and Functions of the CB2 Receptor in Human Leukocytes

M Simard, V Rakotoarivelo, V Di Marzo… - Frontiers in …, 2022 - frontiersin.org
The cannabinoid CB2 receptor was cloned from the promyeloid cell line HL-60 and is
notably expressed in most, if not all leukocyte types. This relatively restricted localization …

Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury

F Jiang, M Xia, Y Zhang, J Chang, J Cao… - Frontiers in …, 2022 - frontiersin.org
Background Neuroinflammation following spinal cord injury (SCI) results in prolonged
neurological damage and locomotor dysfunction. Polarization of microglia is vital to …

Pattern of mitochondrial respiration in peripheral blood cells of patients with Parkinson's disease

T Schirinzi, I Salvatori, H Zenuni, P Grillo… - International Journal of …, 2022 - mdpi.com
Mitochondria are central in the pathogenesis of Parkinson's disease (PD), as they are
involved in oxidative stress, synaptopathy, and other immunometabolic pathways …

Cannabinoid receptor 1 agonist ACEA and cannabinoid receptor 2 agonist GW833972A attenuates cell-mediated immunity by different biological mechanisms

N Takheaw, K Jindaphun, S Pata, W Laopajon… - Cells, 2023 - mdpi.com
Cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) are components in the
endocannabinoid system that play significant roles in regulating immune responses. There …

[HTML][HTML] Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and …

I Zahoor, M Nematullah, ME Ahmed, M Fatma, S Mir… - bioRxiv, 2023 - ncbi.nlm.nih.gov
Multiple sclerosis (MS) is one of the most common inflammatory neurodegenerative
diseases in young adults and causes neurological abnormalities and disability. We studied …

Effect of CB2 stimulation on gene expression in pediatric B-Acute lymphoblastic leukemia: New possible targets

F Punzo, M Argenziano, C Tortora, A Di Paola… - International Journal of …, 2022 - mdpi.com
Acute lymphoblastic leukemia type B (B-ALL) is the most common kind of pediatric leukemia,
characterized by the clonal proliferation of type B lymphoid stem cells. Important progress in …

Cannabinoids' Role in Modulating Central and Peripheral Immunity in Neurodegenerative Diseases

N Sharon, L Yarmolinsky, B Khalfin… - International Journal of …, 2024 - mdpi.com
Cannabinoids (the endocannabinoids, the synthetic cannabinoids, and the
phytocannabinoids) are well known for their various pharmacological properties, including …